TP53 and glioblastoma: Evaluating the transcriptional profile, we detected decreased p53 and PTEN RNA levels after 48 h of TMZ treatment in wt-p53-expressing cells but observed no changes in the p53 and PTEN RNA levels in glioblastoma cells carrying the M237I mutation (Figures S1G and S1H).